Caris Current Deferred Revenue from 2010 to 2026
| CAI Stock | USD 23.16 2.04 8.10% |
Current Deferred Revenue | First Reported 2006-12-31 | Previous Quarter 7.7 M | Current Value 5.3 M | Quarterly Volatility 2.8 M |
Check Caris Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caris Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 61.8 M, Interest Expense of 33.1 M or Total Revenue of 497.8 M, as well as many indicators such as Price To Sales Ratio of 16.34, Dividend Yield of 0.0333 or Days Sales Outstanding of 175. Caris financial statements analysis is a perfect complement when working with Caris Life Valuation or Volatility modules.
Caris | Current Deferred Revenue | Build AI portfolio with Caris Stock |
The Current Deferred Revenue trend for Caris Life Sciences offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Caris Life is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Caris Life's Current Deferred Revenue Growth Pattern
Below is the plot of the Current Deferred Revenue of Caris Life Sciences over the last few years. It is revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. Caris Life's Current Deferred Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caris Life's overall financial position and show how it may be relating to other accounts over time.
| Current Deferred Revenue | 10 Years Trend |
|
Current Deferred Revenue |
| Timeline |
Caris Current Deferred Revenue Regression Statistics
| Arithmetic Mean | 6,363,630 | |
| Geometric Mean | 5,188,276 | |
| Coefficient Of Variation | 48.88 | |
| Mean Deviation | 2,294,724 | |
| Median | 6,862,000 | |
| Standard Deviation | 3,110,569 | |
| Sample Variance | 9.7T | |
| Range | 11.2M | |
| R-Value | (0.08) | |
| Mean Square Error | 10.3T | |
| R-Squared | 0.01 | |
| Significance | 0.77 | |
| Slope | (47,365) | |
| Total Sum of Squares | 154.8T |
Caris Current Deferred Revenue History
About Caris Life Financial Statements
Investors use fundamental indicators, such as Caris Life's Current Deferred Revenue, to determine how well the company is positioned to perform in the future. Although Caris Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 8.6 M | 6.7 M |
Currently Active Assets on Macroaxis
When determining whether Caris Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caris Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caris Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caris Life Sciences Stock:Check out the analysis of Caris Life Correlation against competitors. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is there potential for Trading Companies & Distributors market expansion? Will Caris introduce new products? Factors like these will boost the valuation of Caris Life. Projected growth potential of Caris fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Caris Life Sciences is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Caris Life's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Caris Life should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Caris Life's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.